Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Analysts Weigh Up Benefits Of Big Bayer Restructuring

Nov 30 2018

• By Kevin Grogan

The Thinker — Bayer changes give analysts food for thought • Source: Shutterstock

Related Content

Coppertone, Dr. Scholl’s On The Block As Bayer Narrows Consumer Health Focus

Nov 30 2018

Big Changes At Bayer With Animal Health Exit And 12,000 Jobs Cut

Nov 29 2018

FDA Nod For Loxo/Bayer Tissue Agnostic Drug Marks Paradigm Shift In Cancer

Nov 27 2018

Bayer's Hemophilia A Portfolio Boosted by Jivi's EU Approval

Nov 28 2018

Related Companies

Bayer AG

Boehringer Ingelheim GmbH

Merck & Co., Inc.

Loxo Oncology at Lilly

Sanofi

Takeda Pharmaceutical Co. Ltd.

Novo Nordisk A/S

Roche Holding AG

Additional Topics

Business Strategies M & A Companies Commercial BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window